Filter
196
Filtered Results: 196
Text search:
teste
genotípico
Featured
Recommendations
28
New Publications
52
Language
Document type
No document type
109
Guidelines
39
Studies & Reports
28
Manuals
10
Strategic & Response Plan
7
Training Material
2
Fact sheets
1
Countries / Regions
Western and Central Europe
10
India
9
Eastern Europe
7
Colombia
6
Ethiopia
5
Africa
4
Global
3
Venezuela
3
Latin America and the Carribbean
3
Myanmar / Burma
3
Kenya
2
Estonia
2
Malawi
2
Mozambique
2
Asia
2
South–East Asia Region
2
Paraguay
2
Argentina
2
Bangladesh
2
South Africa
2
Zambia
2
North Macedonia
1
Thailand
1
Lesotho
1
Benin
1
Sierra Leone
1
Chile
1
Nigeria
1
Senegal
1
Philippines
1
USA
1
Tanzania
1
Eastern Europe and Central Asia
1
Uruguay
1
Bolivia
1
Uganda
1
Russia
1
Romania
1
Georgia
1
Botswana
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
33
TB
13
Guidelines
11
Studies & Reports
9
Hepatitis
6
Policies
6
Pediatrics
5
Disease Prevention & Control
5
Bacteriology
4
Vaccine-preventable Diseases
4
HIV & STI
4
Malaria
4
Virology
3
Communicable Diseases
2
Countries
2
Capacity Building
2
Statistics
2
NTDs & Others
2
Non-communicable Diseases
2
Paediatrics
1
Disaster Preparedness
1
COVID-19
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Yellow Fever
1
Other
1
Toolboxes
Detection & Diagnosis
16
Drug resistant TB
12
ART Drug Resistance
11
Eastern Europe and central Asia
7
Surveillance
6
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
6
Adults
5
Children/Adolescents Mental Disorders
5
Children
5
Reports & Studies
5
Agriculture & Veterinary
4
Prevention & Control
4
Treatment Guidelines HIV
4
Drug resistance
4
Ethiopia
4
Studies
4
Training
4
Eastern Europe & Central Asia
4
Moldova
3
Clinical Aspects, Treatment & Prevention
3
Laboratory
3
Colombia
3
Antiretroviral Treatment ART
3
Surveillance
2
Country specific
2
Hepatitis
2
Public Health
2
TB
2
Adherence
2
Laboratory
2
Cannabis
2
General
2
Genomic sequencing
2
Other Countries
2
Clinical Aspects & Diagnostics
2
General
2
Co-Morbidities (except TB)
2
Disease Prevention & Control
2
Assessment
2
TB/HIV Coinfection
2
AmR (Region of Americas)
2
Kenya
2
SEAR (South-east Asia Region)
2
Drugs
1
Outbreak Prevention & Control
1
Policies & Strategies
1
Assessment & Studies
1
Biosafety
1
Meningitis Prevention & Control
1
Childhood TB
1
Laboratory Guidance
1
HIV testing & services
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Clinical Aspects
1
Clinical Guidelines
1
South Africa
1
WPRO (Western Pacific Region)
1
HIV
1
African Region
1
Mozambique
1
Georgia
1
Drug resistance
1
Country Guidelines
1
Reports
1
International
1
IEC Substance Use Disorders
1
Prevention & Preparedness
1
Supporting tools
1
Diagnostics & Laboratory Guidance
1
Clinical Guidelines
1
TB/COVID-19
1
Chile
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
HIV &TB
1
Pharmacovigilance
1
Antimicrobial Resistance (AMR)
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Leptospirosis
1
Prevention & Strategies
1
Others
1
Romania
1
Asia and Pacific
1
Substance Use Disorders & Addiction
1
Research & Access
1
Uganda
1
Clinical Guidelines
1
HIV and coinfection
1
Testing Guidelines
1
Nigeria
1
Chikungunya Prevention & Control
1
Others
1
South-east Asia Region
1
Context & Facts
1
Public Health
1
Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries
This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child...
Unofficial Translation
Approved by the Federal Government on October 20, 2016
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
Copenhagen, Denmark, 24–25 August 2017
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
2018
9th Edition
Offering information on HIV/AIDS treatment, prevention, and research
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Leptospirosis is a bacterial zoonotic disease of worldwide importance, though relatively neglected in many African countries including sub Saharan Africa that is among areas with high burden of this disease. The disease is often mistaken for other febrile illnesses such as dengue, malaria, rickettsi...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
